Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Department of Cardiovascular Medicine, Division of Rhythmology, University Hospital Münster, Schlossplatz 2, 48149 Munich, Germany.
Nat Rev Cardiol. 2016 Apr;13(4):230-7. doi: 10.1038/nrcardio.2015.194. Epub 2015 Dec 24.
Despite remarkable advances in antiarrhythmic drugs, ablation procedures, and stroke-prevention strategies, atrial fibrillation (AF) remains an important cause of death and disability in middle-aged and elderly individuals. Unstructured management of patients with AF sharply contrasts with our detailed, although incomplete, knowledge of the mechanisms that cause AF and its complications. Altered calcium homeostasis, atrial fibrosis and ageing, ion-channel dysfunction, autonomic imbalance, fat-cell infiltration, and oxidative stress, in addition to a susceptible genetic background, contribute to the promotion, maintenance, and progression of AF. However, clinical management of patients with AF is currently guided by stroke risk parameters, AF pattern, and symptoms. In response to this apparent disconnect between the known pathophysiology of AF and clinical management, we propose a roadmap to develop a set of clinical markers that reflect the major causes of AF in patients. Thereby, the insights into the mechanisms causing AF will be transformed into a format that can underpin future personalized strategies to prevent and treat AF, ultimately informing better patient care.
尽管在抗心律失常药物、消融手术和卒中预防策略方面取得了显著进展,但心房颤动(房颤)仍然是中老年人死亡和残疾的重要原因。对房颤患者的管理不规范,这与我们对导致房颤及其并发症的机制的详细但不完整的了解形成鲜明对比。钙稳态失衡、心房纤维化和衰老、离子通道功能障碍、自主神经失衡、脂肪细胞浸润和氧化应激,以及易感的遗传背景,都促成了房颤的发生、维持和进展。然而,目前房颤患者的临床管理是由卒中风险参数、房颤模式和症状来指导的。针对这种房颤已知病理生理学与临床管理之间明显脱节的情况,我们提出了一条路线图,旨在开发一组反映患者房颤主要病因的临床标志物。这样,导致房颤的机制的相关认识就可以转化为一种可以为未来预防和治疗房颤的个性化策略提供支撑的模式,最终为患者提供更好的护理。